Tenofovir Disoproxil Emtricitabine Mylan 300/200 Tablets
Published 14 January 2021
Product
Tenofovir Disoproxil Emtricitabine Mylan 300/200 tenofovir disoproxil maleate 300 mg and emtricitabine 200 mg film coated tablets All batches within expiry ARTG: 265834 Prescription Medicine for: The treatment of HIV-infected adults over the age of 18 years, in combination with other antiretroviral agents. In combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults at high risk.
Why it was recalled
Potential for broken and/or split tablets. In the event a broken/split tablet is consumed, this may result in an ineffective dose if the tablet is not taken in its entirety.
Hazard
A broken or split tablet may lead to ineffective dosing, which may increase the risk of adverse health effects.
Source: Based on ACCC data or other content. ACCC © Commonwealth of Australia. ACCC-owned material is licensed under CC BY 4.0. RecallMatch extracts and formats notice information for screening. Third-party material may have separate rights. Source and reuse terms. Verify details in the official notice. RecallMatch is independent of the ACCC.